ARCHIVES

Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 1 | January 27, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities listed.

May 21, 2004

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

Court Orders NIH To Retract Electronic Annotations On Fisher Publications

March 24, 1995

The Cancer Letter Wins Journalism Award

April 1, 2011

NCI Phone Number Listings Completed

September 21, 1979

Society Recognizes Community Oncologists (8-page issue).

June 6, 2003